Matches in Wikidata for { <http://www.wikidata.org/entity/Q91266579> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q91266579 description "article scientifique (publié 2019)" @default.
- Q91266579 description "articolo scientifico (pubblicato il 2019)" @default.
- Q91266579 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q91266579 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91266579 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91266579 description "scientific article published on 01 January 2019" @default.
- Q91266579 description "wetenschappelijk artikel" @default.
- Q91266579 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q91266579 description "научна статия" @default.
- Q91266579 name "Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial" @default.
- Q91266579 name "Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial" @default.
- Q91266579 name "Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial" @default.
- Q91266579 type Item @default.
- Q91266579 label "Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial" @default.
- Q91266579 label "Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial" @default.
- Q91266579 label "Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial" @default.
- Q91266579 prefLabel "Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial" @default.
- Q91266579 prefLabel "Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial" @default.
- Q91266579 prefLabel "Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial" @default.
- Q91266579 P1433 Q91266579-0CDE7C2C-628E-4DA0-BA6E-B510034A52F6 @default.
- Q91266579 P1476 Q91266579-31BE2422-FFB2-4BE6-BF45-64F4811D6DAA @default.
- Q91266579 P2093 Q91266579-0AEA54CE-79FA-46BD-A932-1E3C98C6A8BC @default.
- Q91266579 P2093 Q91266579-36171098-9D08-4E8D-8430-99A7B29D70C0 @default.
- Q91266579 P2093 Q91266579-3744C83F-6EA3-4C74-8445-15A9E79F71AE @default.
- Q91266579 P2093 Q91266579-496FD0EA-27DB-4AAC-ADCC-CA03557BC417 @default.
- Q91266579 P2093 Q91266579-5A019EAE-6521-40D0-A87E-6ABFB162AD30 @default.
- Q91266579 P2093 Q91266579-6996BF58-DD45-4ADB-9695-88A96BEC9591 @default.
- Q91266579 P2093 Q91266579-6EE52F1B-DF9E-4607-92E8-D7A6AD0768E9 @default.
- Q91266579 P2093 Q91266579-C134F56F-AE1F-4735-A66B-7B6C8F4DAAFA @default.
- Q91266579 P2093 Q91266579-CAF829E1-3593-47BF-A7D6-DC12ADD55EEC @default.
- Q91266579 P2093 Q91266579-EC59FCBC-CEA4-4D4C-B064-05FCD9BFD413 @default.
- Q91266579 P304 Q91266579-F5F9A6BC-5467-4D31-AFC3-7461C64EE04E @default.
- Q91266579 P31 Q91266579-340CFE19-1736-47B0-A115-B8D52FCAADF4 @default.
- Q91266579 P356 Q91266579-37F7FF24-3A19-4641-A72C-BE7101F8E37D @default.
- Q91266579 P433 Q91266579-234E8AA7-60AE-45DE-874F-8046A6438872 @default.
- Q91266579 P478 Q91266579-F94F5EF6-6A0F-46EE-BB22-545802C76E9C @default.
- Q91266579 P577 Q91266579-E9522954-C0AB-4BDB-88DF-8F8B1EAA2669 @default.
- Q91266579 P698 Q91266579-BFCB5D96-30C5-4755-A7CF-DC082E60D20D @default.
- Q91266579 P921 Q91266579-0BAD603F-94B2-4EA4-8445-71B053C63E3E @default.
- Q91266579 P921 Q91266579-57B6D0F1-0882-435A-9807-F511AFB3752F @default.
- Q91266579 P921 Q91266579-67D8A2DE-9917-4B8D-B822-2077A323269D @default.
- Q91266579 P921 Q91266579-9C36007F-F3B1-45F9-AFD8-28BD5C126DF2 @default.
- Q91266579 P921 Q91266579-FD123B05-9645-4A9A-A1A3-60722714B649 @default.
- Q91266579 P932 Q91266579-0E15EF6F-1CEA-4620-821B-395AD053DABE @default.
- Q91266579 P356 GME.0000000000001292 @default.
- Q91266579 P698 30694917 @default.
- Q91266579 P1433 Q6817295 @default.
- Q91266579 P1476 "Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial" @default.
- Q91266579 P2093 "Arthur S Waldbaum" @default.
- Q91266579 P2093 "Corrado Altomare" @default.
- Q91266579 P2093 "David F Archer" @default.
- Q91266579 P2093 "Graziella Soulban" @default.
- Q91266579 P2093 "James A Simon" @default.
- Q91266579 P2093 "Julie Zhu" @default.
- Q91266579 P2093 "Sam Schaffer" @default.
- Q91266579 P2093 "Steven A Sussman" @default.
- Q91266579 P2093 "Steven R Goldstein" @default.
- Q91266579 P2093 "Yuki Yoshida" @default.
- Q91266579 P304 "611-621" @default.
- Q91266579 P31 Q13442814 @default.
- Q91266579 P356 "10.1097/GME.0000000000001292" @default.
- Q91266579 P433 "6" @default.
- Q91266579 P478 "26" @default.
- Q91266579 P577 "2019-01-01T00:00:00Z" @default.
- Q91266579 P698 "30694917" @default.
- Q91266579 P921 Q1872899 @default.
- Q91266579 P921 Q269829 @default.
- Q91266579 P921 Q42824827 @default.
- Q91266579 P921 Q5309747 @default.
- Q91266579 P921 Q6934595 @default.
- Q91266579 P932 "6553508" @default.